Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Petadolex

This article was originally published in The Tan Sheet

Executive Summary

Botanical migraine formula containing butterbur root extract "significantly reduced the frequency of migraine attacks and days with migraine per month as well as the frequency of accompanying symptoms" compared to placebo, write Alexander Mauskop, MD, New York Headache Center, et al,. in the May issue of Headache: The Journal of Head and Face Pain. Clinical trials of the product underway at four U.S. sites and six European sites will encompass a total of 245 subjects. German pharmaceutical firm Weber & Weber sells the supplement in the U.S. through pharmacies, health food stores and the company's Web site (www.migraineaid.com)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091493

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel